Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
56
datasets available to search
ShareScore release 0.9.0
Dataset results
56 results for “pathologic complete response”
Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT01401959. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features
ClinicalTrials.gov study NCT07181850. IPD Sharing: NO. Countries: 1. Publications: 4.
A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
Open the record for dataset details and reuse information.
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
ClinicalTrials.gov study NCT05416164. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
ClinicalTrials.gov study NCT04018872. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06854107. IPD Sharing: Not stated. Countries: 1. Publications: 35.
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoad
ClinicalTrials.gov study NCT05629585. IPD Sharing: YES. Countries: 17. Publications: 1.
Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
ClinicalTrials.gov study NCT03601689. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Complete Pathologic Response Rectal Cancers
ClinicalTrials.gov study NCT03351959. IPD Sharing: NO. Countries: 1. Publications: 36.
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
ClinicalTrials.gov study NCT04928261. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review
ClinicalTrials.gov study NCT05931042. IPD Sharing: NO. Countries: 1. Publications: 9.
MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer
ClinicalTrials.gov study NCT04909554. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
ClinicalTrials.gov study NCT05563766. IPD Sharing: NO. Countries: 1. Publications: 4.
Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients
ClinicalTrials.gov study NCT06631066. IPD Sharing: NO. Countries: 1. Publications: 2.
Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT02575612. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT02948764. IPD Sharing: YES. Countries: 1. Publications: 5.
Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer
ClinicalTrials.gov study NCT01648894. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT03872388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemot
ClinicalTrials.gov study NCT02971748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer
ClinicalTrials.gov study NCT07269691. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.